Liposome and Proliposome Based Drug Delivery - Nanjwade, Basavaraj;Patel, Jigar M.
38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
19 °P sammeln
  • Broschiertes Buch

A promising strategy to overcome these problems involves the development of suitable drug carrier system. The In vivo fate of the drug is no longer mainly determined by the properties of the drug, but by the carrier system, which permit a controlled and localized release of the active drug according to the specific needs of the therapy. The size of the carrier depends on the desired route of administration and ranges from few nanometers to micrometers (implants). Implants and microparticles are too large for drug targeting and intravenous administration. Therefore, colloidal carriers have…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A promising strategy to overcome these problems involves the development of suitable drug carrier system. The In vivo fate of the drug is no longer mainly determined by the properties of the drug, but by the carrier system, which permit a controlled and localized release of the active drug according to the specific needs of the therapy. The size of the carrier depends on the desired route of administration and ranges from few nanometers to micrometers (implants). Implants and microparticles are too large for drug targeting and intravenous administration. Therefore, colloidal carriers have attracted increasing attention during recent years. Investigated systems include nanoparticles, nanoemulsions, liposomes, niosomes, nanosuspensions, micelles, and soluble polymer-drug conjugates.
Autorenporträt
Prof. Dr. Basavaraj Nanjwade arbeitet als Professor und Dekan/Rektor am Surya College of Pharmacy, Bengaluru, Karnataka, Indien. Global Business Development Manager bei Legis Consulting (Indien). Er hat 126 biomedizinische Produkte für den nationalen und internationalen Markt entwickelt. Dr. Nanjwade hat außerdem 173 nationale und internationale Publikationen verfasst.